NEW ORLEANS —A triple receptor agonist provided weight loss for adults with obesity, with or without type 2 diabetes, to an extent not seen with previous pharmacotherapy options, according to data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results